Drug Development Advisory Group

The PKD Foundation's drug development initiative is aimed at accelerating the discovery of PKD therapies to help patients and their loved ones live healthier and happier lives. The DDAG is made up of world-renowned specialists in drug development who have been charged with prioritizing drug targets, identifying potential compounds and regularly evaluating results to ensure success.

 
 

Board Chair

 

John M. McCall, Ph.D
PharMac LLC

 

 

Members

 

Jill A. Panetta, Ph.D

PKD Foundation

 

JoAnn Scatina, Ph.D
Wyeth (Retired)

 

Don Frail, Ph.D
Pfizer Worldwide Research and Development

 
Jim Bristol
Pfizer (Retired)

 

Larry Gelber, Ph.D
Lilly Research Laboratories

 

Claire Deselle
Maine Institute for Human Genetics and Health

 

About The PKD Foundation

 

If you are interested in advertising opportunities, please contact us at 816-931-2600 or pkdcure@pkdcure.org